Division of AstraZeneca PLC
Latest From Zeneca Pharmaceuticals
This week's roundup includes executive appointments by Gilead Sciences, Nordic Nanovector, Mereo BioPharma, vasopharm and Rigontec. Biogen has also appointed two executives to its planned spin-off company, Bioverativ.
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- AstraZeneca PLC
- Senior Management
Michael O'Brien, CEO
J. Goddard, Dir., Fin.
M. Asbury, Dir., Mktg.
Robert D Nolan, Intl. Product Licensing Manager
Ronald Krall, MD, VP, Head of Clinical Dev.
- Contact Info
Phone: (44) 1 625 582828
Macclesfield, SK10 4TF
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.